SEARCH

SEARCH BY CITATION

References

  • 1
    Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk for trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Lancet 1998; 18: 519521.
  • 2
    Nicolaides KH, Azar GB, Byrne D, Mansur CA, Marks K. Nuchal translucency: ultrasound screening for chromosomal defects in the first trimester of pregnancy. BMJ 1992; 304: 867869.
  • 3
    Pandya PP, Snijders RJM, Johnson SP, Brizot ML, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957962.
  • 4
    Snijders RJM, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. Maternal age and gestation specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999; 13: 167170.
  • 5
    Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alphafetoprotein level. Br J Obstet Gynaecol 1987; 94: 387402.
  • 6
    Reynolds T, Penney M. The mathematical basis of multivariate risk analysis with special reference to screening for Down syndrome associated pregnancy. Ann Clin Biochem 1990; 27: 452458.
  • 7
    Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first trimester screening for Down's syndrome. Prenat Diagn 1997; 17: 821829.
  • 8
    Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH. One-stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnancies. Ultrasound Obstet Gynecol 2002; 20: 219225.
  • 9
    Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years' prospective experience. Br J Obstet Gynaecol 2003; 110: 281286.
  • 10
    Royston P, Thompson SG. Model based screening for risk with application to Down's syndrome. Stats Med 1992; 16: 11151119.
  • 11
    Office of National Statistics. Birth Statistics Series FM1 No. 27 (2000). The Stationery Office: London, 2001.
  • 12
    Bowman AW, Azzalini A. Applied Smoothing Techniques for Data Analysis. The Kernel Approach with S-Plus Illustrations. Oxford University Press: Oxford, 1997.
  • 13
    Donovan CM. Statistical aspects of fetal screening. PhD thesis, University of Plymouth, Plymouth, UK, 1995.
  • 14
    Biagiotti R, Periti E, Brizzi L, Vanzi E, Cariati E. Comparison between two methods of standardization for gestational age differences in fetal nuchal translucency measurement in first-trimester screening for trisomy 21. Ultrasound Obstet Gynecol 1997; 9: 248252.
  • 15
    Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. Br J Obstet Gynaecol 2002; 109: 667676.
  • 16
    Spencer K, Crossley JA, Aitken DA, Nix ABJ, Dunstan FDJ, Williams K. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Ann Clin Biochem 2002; 39: 567576.
  • 17
    Spencer K, Crossley JA, Aitken DA, Nix ABJ, Dunstan FDJ, Williams K. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimester of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome. Ann Clin Biochem 2003; 40: 219231.